Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1991-11-15
1993-04-20
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514573, 560121, 562503, C07C17700, A61K 31557
Patent
active
052043711
ABSTRACT:
Compounds of the formula ##STR1## wherein the 9-chlorine atom can be in the .alpha.-or .beta.-position,
REFERENCES:
patent: 4192799 (1988-03-01), Fitzpatrick
patent: 4444788 (1984-04-01), Skuballa et al.
Muchowski, "Synthesis and Bronchial Dilator Activity," Chemistry, Biochemistry & Pharmacological Activity of Prostanoids, Pergamon Press (Jul. 10-14, 1978).
Binder et al., "16-Aryloxprostaglandins: A New Class of Ptent Luteolytic Agent," Prostaglandins, vol. 6, No. 1, pp. 87-91 (Apr. 10, 1974).
Corey et al., "Total Synthesis of Prostaglandins F.sub.2 and E.sub.2 as the Naturally Occurring Forms," J. of the Amer. Chem. Soc., 92:2, pp. 397-398 (Jan. 28, 1970).
Arroniz, Prostaglandius, 16, 47 (1978).
Elger Walter
Loge Olaf
Raduechel Bernd
Schillinger Ekkehard
Skuballa Werner
Gerstl Robert
Schering Aktiengesellschaft
LandOfFree
Pharmaceutically active 9-chloroprostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically active 9-chloroprostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active 9-chloroprostaglandins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1526472